期刊文献+

不同类型HBV感染者T细胞对HBV抗原蛋白的免疫应答研究 被引量:2

The immune response of T cell to HBV antigen protein in different types HBV infecting
下载PDF
导出
摘要 目的:探讨不同临床表现形式HBV感染者T细胞免疫应答功能。方法:分离外周血单核细胞,流式细胞术检测患者T细胞亚群,酶联免疫斑点技术检测患者T细胞对HBV抗原的免疫应答反应。结果:与急性乙型肝炎患者(A组)比较,慢性肝炎感染患者(B组)和无症状携带者(C组)CD4+T细胞亚群频率均显著降低(P<0.01),而3组CD8+T细胞亚群频率差异无统计学意义(P>0.05);与A组比较,B组和C组CD4+/CD8+比值均明显下降(P<0.01);A组斑点形成细胞显著少于B组和C组(P<0.01);B组斑点形成细胞亦显著少于C组(P<0.01)。结论:不同临床表现形式的患者T细胞免疫存在不同,而T细胞亚群之间的平衡失调可能导致机体免疫紊乱,不能清除病毒,是HBV感染患者表现不同临床症状的原因。 Objective: To explore the T cell immune response function in different clinical manifestation patients. Methods: The peripheral blood mononuclear cells were isolated. The T cell subgroup was detected using flow cytometry, and the immune response of T cell to HBV antigen protein was detected using enzyme-linked immunespots assay. Results : Compared with the acute hepatitis patients (group A), the frequency of CD4^T cell subgroup in chronic hepatitis patients (group B) and asymptomatic carriers (group C) were significantly lower( P 〈 0.01 ), and the differences of the frequency of CD8^T cell subgroup in 3 groups were not statistically significant ( P 〉 0.05 ). Compared with group A, the ratios of CD4^/CD8^ in group B and group C were decreased ( P 〈 0.01 ). The spof forming call in group A was significantly less than that in group B and group C ( P 〈 0. 01 ), and the spof forming call in group B was significantly less than that in group C ( P 〈 0.01 ). Conclusions : T cell immune in patients with different clinical manifestations is different, and the dysequilibrium of T cell subgroup may lead to immune disorders, and can not clear the virus, which is the cause of different clinical symptoms.
出处 《蚌埠医学院学报》 CAS 2015年第12期1621-1623,共3页 Journal of Bengbu Medical College
基金 延安大学高水平大学学科建设基础医学资助项目(2013SXTS02)
关键词 乙型肝炎病毒 T细胞 抗原免疫蛋白 免疫应答 hepatitis B virus T cell immune antigen protein immune response
  • 相关文献

参考文献14

  • 1Ziaee M,Azarkar G.Prevalence of hepatitis d virus infection among patients with chronic hepatitis B attending birjand hepatitis clinic(East of Iran) in 2012[J].Hepat Mon,2013,13(8):e11168. 被引量:1
  • 2Liaw YF,Chu CM.Hepatitis B virus infection[J].Lancet,2009,37(63):582-592. 被引量:1
  • 3Ocama P,Opio CK,Lee WM.Hepatitis B virus infection:current status[J].Am J Med,2005,118(12):1413. 被引量:1
  • 4Kosaka K,Hiraga N,Imamura M,et al.A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections[J].Biochem Biophys Res Commun,2013(13):1712-1719. 被引量:1
  • 5McMahon BJ.Epidemiology and natural history of hepatitis B[J].Semin Liver Dis,2005,25(Suppl 1):3-8. 被引量:1
  • 6Yuen MF,Tanaka Y,Fong DY,et al.Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B[J].J Hepatol,2009,15(10):80-88. 被引量:1
  • 7El-Serag HB,Rudolph KL.Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J].Gastroenterology,2007,13(7):2557-2576. 被引量:1
  • 8章晓联编著..病毒免疫学[M].北京:科学出版社,2010:304.
  • 9慢性乙型肝炎防治指南2010年更新版[J].中华实验和临床感染病杂志(电子版),2011,5(1):50-60. 被引量:240
  • 10病毒性肝炎防治方案[J].传染病信息,2000,13(4):141-150. 被引量:267

二级参考文献21

共引文献511

同被引文献32

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部